The short version
23 companies supply this market — deep enough that no single failure threatens the supply. The generic price has fallen 30% in a year, to $5.81 per mL — and generics that get this cheap tend to get abandoned rather than defended. It is in shortage right now — FDA lists the reason as “other”.